Adjuvant therapy with nivolumab (Opdivo, “nivo”) continues to show disease-free survival (DFS) and overall survival (OS) benefits compared with placebo among patients with muscle-invasive ...

Adding nivolumab to neoadjuvant chemotherapy significantly increases pathological complete response rates. (HealthDay News) — For patients with high-risk, early-stage estrogen receptor (ER ...

nanoPLM also got announced at FOSDEM 2025 in my talk about "Product development in mechanical engineering using open-source software". Product Lifecycle Management (PLM) software is designed to manage ...

Nivolumab plus ipilimumab is being reviewed by the FDA as a first-line treatment for advanced colorectal cancer, with a decision expected by June 2025. The FDA accepted the supplemental biologics ...

然而，传统的产品评审流程却常常成为制约企业效率提升的瓶颈，诸多问题亟待解决。智橙 PLM 的 3D 模型评审功能宛如一把利刃，精准切入这些痛点，为制造业带来全新的解决方案。 “公司成立这么多年，一直用的国外的PLM软件，坦白讲，对我们这小企业来讲 ...